Coral Laboratories Ltd share price logo

Coral Laboratories Share Price

BSE: 524506

Small Cap

Healthcare Sector

₹398.95

+6.00

(+1.53%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

Coral Laboratories Stock Performance

as on April 6, 2026 at 4:08 pm IST

  • Day's Low

    Day's High

    ₹391.00
    ₹404.75
    downward going graph

    1.99%

    Downside

    1.45%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹360.00
    ₹784.55
    downward going graph

    9.76%

    Downside

    96.65%

    Upside

    downward going graph

Coral Laboratories share price movements today

Previous Close
₹392.95
Open
₹398.95
Volume
436.00
Upper Circuit
₹471.50
Lower Circuit
₹314.40
Day's Low - High
₹391.00 - ₹404.75
52 Week Low - High
₹360.00 - ₹784.55

Coral Laboratories Historical Returns

1 Month Return
-9.16 %
3 Month Return
-13.44 %
1 Year Return
-38.93 %
3 Year Return
+ 56.24 %
5 Year Return
+ 17.83 %

Coral Laboratories Fundamentals

as on April 6, 2026 at 10:38 am IST

Market Cap

₹140.28 Cr

Return on Equity (ROE)

12.76

PE Ratio (TTM)

0

Return on capital employed (ROCE)

16.98

Beta (LTM)

0.53

P/B Ratio

1.25

Dividend Yield

0

PEG Ratio

0

Quarterly Earnings Growth YOY

-54.72

EPS (TTM)

0

Sector

Pharmaceuticals

Book Value

0

Technical Analysis

Bearish

View Technical Analysis

Coral Laboratories Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Coral Laboratories with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Coral Laboratories Ltd image
Coral Laboratories Ltd
NA140.283.57%0.0024115
Haleos Labs Limited image
Haleos Labs Limited
NA389.3129.4%0.6818344
Mangalam Drugs and Organics Ltd image
Mangalam Drugs and Organics Ltd
NA46.77-14.89%0.706318
Themis Medicare Ltd image
Themis Medicare Ltd
NA729.6231.63%0.5929405
Syncom Formulations (India) Ltd image
Syncom Formulations (India) Ltd
NA1,062.2052.9%0.5149465
See all

Coral Laboratories Stock’s Investor Sentiment and Interest

Search interest for Coral Laboratories Ltd Stock has decreased by -44% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-44% versus previous 30 day period

Coral Laboratories Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Sales
13.55
23.15
18.08
28.89
31.66
32.23
22.99
28.13
18.82
19.03
21.56
Other Income
1.29
1.81
1.44
2.09
1.56
2.54
2.52
2.48
2.05
3.03
2.49
Total Income
14.84
24.96
19.52
30.98
33.22
34.77
25.51
30.62
20.87
22.07
24.06
Expenses
11.81
17
16.05
22.73
20.92
25.72
16.67
26.22
16.64
14.1
19.67
Operating Profit
1.74
6.15
2.03
6.16
10.74
6.51
6.32
1.91
2.18
4.93
1.89
Operating Profit Margin %
12.84%
26.57%
11.23%
21.32%
33.92%
20.2%
27.49%
6.79%
11.58%
25.91%
8.77%
Profit Before Interest, Tax and Depreciation
3.03
7.96
3.47
8.25
12.3
9.05
8.84
4.4
4.23
7.97
4.38
Interest
-
-
-
-
0.03
0.01
0.02
0.04
0.06
0.1
-
Depreciation
0.55
0.44
0.49
0.5
0.49
0.51
0.5
0.51
0.45
0.45
0.69
Profit Before Tax
2.48
7.52
2.98
7.75
11.78
8.53
8.32
3.85
3.72
7.42
3.69
Tax Paid
0.65
1.52
0.82
1.95
2.97
2.15
2.17
1.02
1.16
1.6
0.92
Profit After Tax
1.84
6
2.16
5.79
8.8
6.38
6.14
2.83
2.56
5.82
2.78
Total Net profit including share of profit / Loss from associate company
1.84
6
2.16
5.79
8.8
6.38
6.14
2.83
2.56
5.82
2.78
EPS
5.16
16.81
6.04
16.2
24.64
17.86
17.2
7.91
7.18
16.29
7.77
Actual EPS
5.16
16.81
6.04
16.2
24.64
17.86
17.2
7.91
7.18
16.29
7.77
Adjusted EPS
5.16
16.81
6.04
16.2
24.64
17.86
17.2
7.91
7.18
16.29
7.77
Diluted EPS
5.16
16.81
6.04
16.2
24.64
17.86
17.2
7.91
7.18
16.29
7.77

Coral Laboratories Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Sales
92.47
91.08
70.58
96.57
75.61
78.12
83.66
115.01
Other Income
4.47
5.16
5.89
3.79
5.77
6.93
6.63
9.11
Total Income
96.94
96.24
76.47
100.36
81.38
85.05
90.29
124.11
Expenses
77.3
78.8
65.29
80.72
67.4
74.31
67.59
89.54
Operating Profit
15.17
12.28
5.29
15.85
8.21
3.81
16.07
25.47
Operating Profit Margin %
16.41%
13.48%
7.5%
16.41%
10.86%
4.88%
19.21%
22.15%
Profit Before Interest, Tax and Depreciation
19.64
17.43
11.18
19.64
13.99
10.74
22.71
34.58
Interest
0.03
0.02
0.06
0.04
0.14
0.34
-
0.1
Depreciation
1.56
1.9
2.01
1.98
1.99
2.18
1.98
2.01
Profit Before Tax
18.05
15.51
9.11
17.62
11.86
8.22
20.73
32.47
Tax Paid
5.6
5.29
1.99
4.06
2.81
1.78
4.94
8.31
Profit After Tax
12.45
10.22
7.13
13.55
9.05
6.45
15.79
24.16
Total Net profit including share of profit / Loss from associate company
12.45
10.22
7.13
13.55
9.05
6.45
15.79
24.16
EPS
34.84
28.6
19.96
37.94
25.32
18.04
44.19
67.61
Actual EPS
34.84
28.6
19.96
37.94
25.32
18.04
44.19
67.61
Adjusted EPS
34.84
28.6
19.96
37.94
25.32
18.04
44.19
67.61
Diluted EPS
34.84
28.6
19.96
37.94
25.32
18.04
44.19
67.61

Coral Laboratories Ltd Cash Flow

Figures in Rupees Crores

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Cash from Operating Activities
5.05
10.77
13.47
-0.88
-3.86
0.93
6.08
12.67
-5.46
-1.22
Cash Flow from Investing Activities
-2.72
-9.8
-13.21
3.22
-1.55
-0.07
-6.05
-2.62
1.4
2.33
Cash Flow from Financing Activities
-0.05
0.48
-2.62
-1.18
3.56
0.35
0.15
-6.43
0.01
2.71
Net Cash Flow
2.28
1.45
-2.36
1.17
-1.86
1.21
0.18
3.62
-4.06
1.33

Coral Laboratories Stock Shareholding Pattern

Numbers in percentages

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Promoters
71.51%
71.51%
71.51%
71.51%
71.51%
71.51%
71.51%
71.51%
71.51%
71.51%
71.51%
FII
0%
0.14%
0.14%
0.14%
0.23%
0%
0%
0%
0%
0%
0%
Public
28.35%
28.35%
28.35%
28.35%
28.26%
28.49%
28.49%
28.49%
28.49%
28.49%
28.49%
Total Outstanding Shares
35,72,600
35,72,600
35,72,600
35,72,600
35,72,600
35,72,600
35,72,600
35,72,600
35,72,600
35,72,600
35,72,600
Total Shareholders
4,040
3,981
4,005
4,098
3,831
3,949
4,054
4,105
4,213
4,286
4,208

Coral Laboratories Corporate Actions

View detailed summary of the earnings and dividend history of Coral Laboratories.

  • Coral Laboratories Ltd Earnings Results

    Coral Laboratories Ltd’s net profit fell -54.72% since last year same period to ₹2.78Cr in the Q3 2025-2026. On a quarterly growth basis, Coral Laboratories Ltd has generated -52.23% fall in its net profits since last 3-months.

    Read More about Earnings Results

  • Coral Laboratories Ltd Dividends May,2025

    In the quarter ending March 2025, Coral Laboratories Ltd has declared dividend of ₹1.50 per share on 30 May 2025 - translating a dividend yield of 0.89%.

    Read More about Dividends

Insights on Coral Laboratories Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Lupin Ltd has given 245.2% return, outperforming this stock by 180.5%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 71.51% of holdings in Dec 2025 quarter

  • imgNO EFFECT

    Retail Holding Unchanged

    img

    Retail Investor holdings remained unchanged at 28.49% of holdings in Dec 2025 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Torrent Pharmaceuticals Ltd has given 23.3% return, outperforming this stock by 62.2%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 year, Coral Labs. stock has moved down by -38.9%

About Coral Laboratories Ltd

Coral Laboratories Limited (CLL), based in India and headed by Kishor R Mehta as Executive Director, produces various pharmaceutical formulations such as tablets and capsules. CLL went into public issue in March 1994 at a total cost of Rs.2.5 crores and has since successfully expanded its activities into the sophisticated FFS form fill and seal technology for injections, with all required machinery to be imported. To further expand, the company has also diverted into housing construction and financial services in order to create a new company, Coral India Finance and Housing. Additionally, CLL has also received the prestigious ISO9002 Certification, in the year 19992000. Promoted by Navin B Doshi of the DWD group, CLL is expanding its avenues to ensure that the highest quality pharmaceutical formulations are provided to its customers.

Revenue: ₹21.56Cr as on December 2025 (Q3 FY26)
Net Profit: ₹2.78Cr as on December 2025 (Q3 FY26)
OrganisationCoral Laboratories Ltd
HeadquartersMumbai
IndustryPharmaceuticals
E-voting on sharesClick here to vote

FAQs

What is Coral Laboratories share price today?

Coral Laboratories share price today stands at ₹398.95 as on . Coral Laboratories share today touched a day high of ₹404.75 and a low of ₹391.

What is the 52 week high and 52 week low range for Coral Laboratories share?

Coral Laboratories touched a 52 week high of ₹784.55 and a 52 week low of ₹360. Coral Laboratories share price today i.e. is trending at ₹398.95, which is -49.15% down from its 52 week high and 10.82% up from its 52 week low.

What is Coral Laboratories's market capitalisation today?

Coral Laboratories market capitalisation is ₹140.28 Cr as on .

How to buy Coral Laboratories shares?

To buy Coral Laboratories shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for 524506 or Coral Laboratories Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Coral Laboratories shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Coral Laboratories trading volume today?

Coral Laboratories trading volume is 436.00 as on . This means that 436.00 shares of Coral Laboratories were bought and sold on the stock market during today's trading session.